Anadis Ltd. (ASX:ANX; OTC:ANDIY) an Australian biopharmaceutical company has been awarded a product development grant for its Cancer-related Alimentary Mucositis project. The award was one of only three made by the VISTECH bi-national fund, following a competitive process, which included a thorough scientific assessment. The fund was established by the Government of Victoria (Australia) and the Government of Israel through the Office of the Chief Scientist in its Ministry of Industry Trade and Labor. The intended product for the oncology market will leverage a special formulation of Anadis' immune milk-derived anti LPS antibodies, growth factors and other bioactives delivered using Anadis’ oral delivery technology.

Anadis Ltd (ASX:ANX; OTC:ANDIY), a biopharmaceutical company focused on research, development and production of immune milk (colostrum)-derived polyclonal antibodies and other proteins to address major diseases, today announces the initiation of a clinical trial with top clinical scientists at Tel Aviv Sourasky Medical Center in Israel. The clinical trial will explore the efficacy of a formulation developed by Anadis to address the symptoms of Inflammatory Bowel Disease (IBD), a serious chronic condition effecting millions of persons annually. (PRWeb Jul 21, 2008)

Read the fu

Anadis Ltd (ASX:ANX; OTC:ANDIY), a biopharmaceutical company focused on research, development and production of immune milk (colostrum)-derived polyclonal antibodies and other proteins to address major diseases, today announces the initiation of a clinical trial with top clinical scientists at Tel Aviv Sourasky Medical Center in Israel. The clinical trial will explore the efficacy of a formulation developed by Anadis to address the symptoms of Inflammatory Bowel Disease (IBD), a serious chronic condition effecting millions of persons annually. (PRWeb Jul 21, 2008)

Habitech Design & Development Works, in collaboration with TRICOR Systems, designed and engineered an award winning product for Milestone Scientific. This new product technology has provided Milestone to expand their market penetration and sales. (PRWeb Jun 14, 2008)

Read the full story at http://www.prweb.com/releases/2008/06/prweb1024594.htm

The Wellness Community, based in Walnut Creek, CA, awarded a HEDCO Foundation grant to expand its facility to support increased cancer support services for cancer patients and their families. (PRWeb Jun 11, 2008)

Read the full story at http://www.prweb.com/releases/2008/06/prweb1006884.htm

The Wellness Community, based in Walnut Creek, CA, awarded a HEDCO Foundation grant to expand its facility to support increased cancer support services for cancer patients and their families. (PRWeb Jun 11, 2008)

Read the full story at http://ca.prweb.com/releases/2008/06/prweb1006884.htm

Grant Life Sciences (OTC Bulletin Board: GLIF) announced today it has received a waiver from The N.I.R. Group, LLC ("N.I.R. Group"), a Roslyn, N.Y.-based hedge fund that allows Grant to pursue alternate financing to pay down, in whole or in part, an existing financing debt to N.I.R. (PRWeb Mar 31, 2008)

Read the full story at http://ca.prweb.com/releases/grant/life_sciences/prweb818254.htm

Grant Life Sciences (OTC Bulletin Board: GLIF) announced today it has received a waiver from The N.I.R. Group, LLC ("N.I.R. Group"), a Roslyn, N.Y.-based hedge fund that allows Grant to pursue alternate financing to pay down, in whole or in part, an existing financing debt to N.I.R. (PRWeb Mar 31, 2008)

Read the full story at http://www.prweb.com/releases/grant/life_sciences/prweb818254.htm